Logo image
Fluorescence properties of methylene blue conjugated to normal/cancerous human tissues for spectral discrimination of breast cancer stages (I-IV)
Journal article   Open access   Peer reviewed

Fluorescence properties of methylene blue conjugated to normal/cancerous human tissues for spectral discrimination of breast cancer stages (I-IV)

Romina Khoshnevisan, Parviz Parvin, Fatemeh Ramezani, Danial Noroozian, Nahid Nafissi, Parisa Mohammadi Matin, Ahmad Shariftabrizi, Fatemeh Atyabi and Somayyeh Hashamdar
Biomedical optics express, Vol.17(4), pp.2111-2132
04/01/2026
DOI: 10.1364/BOE.591357
url
https://doi.org/10.1364/BOE.591357View
Published (Version of record) Open Access

Abstract

Laser-induced fluorescence (LIF) spectroscopy is utilized to differentiate normal/malignant breast cells/tissues and classify cancer stages, using the biocompatible methylene blue (MB) fluorophore. Cancerous cells (MCF-7) conjugated with MB exhibit a red shift of 3.96 ± 0.41 nm, corresponding to ∼2.5 times higher signal intensity versus normal cells (MCF-10A). Regarding stages, tissue-level fluorescence intensity is elevated ∼2.5 times in stage I and ∼8 times in stage IV relative to healthy ones, with red-shifts ranging from 3.73 ± 0.75 nm in stage I to 18.56 ± 2.15 nm in stage IV. Thus, the LIF-MB technique offers a rapid, non-invasive method for both the early detection and grading of malignant tumors. The novelty of this work arises from the synergic contribution of the LIF and gravimetric validation for breast cancer staging.

Details

Metrics

1 Record Views
Logo image